Logo image of LASE

LASER PHOTONICS CORP (LASE) Stock Fundamental Analysis

NASDAQ:LASE - Nasdaq - US51807Q1004 - Common Stock - Currency: USD

2.59  -0.1 (-3.72%)

Premarket: 2.5916 +0 (+0.06%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LASE. LASE was compared to 128 industry peers in the Machinery industry. While LASE has a great health rating, there are worries on its profitability. LASE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LASE had negative earnings in the past year.
In the past year LASE has reported a negative cash flow from operations.
LASE Yearly Net Income VS EBIT VS OCF VS FCFLASE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -2M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -103.45%, LASE is doing worse than 92.97% of the companies in the same industry.
LASE has a worse Return On Equity (-113.41%) than 86.72% of its industry peers.
Industry RankSector Rank
ROA -103.45%
ROE -113.41%
ROIC N/A
ROA(3y)-7.15%
ROA(5y)N/A
ROE(3y)-7.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LASE Yearly ROA, ROE, ROICLASE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

The Gross Margin of LASE (45.56%) is better than 86.72% of its industry peers.
LASE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for LASE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.39%
GM growth 5YN/A
LASE Yearly Profit, Operating, Gross MarginsLASE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 50 -50

More info and screens

8

2. Health

2.1 Basic Checks

LASE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LASE has been increased compared to 1 year ago.
There is no outstanding debt for LASE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LASE Yearly Shares OutstandingLASE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M
LASE Yearly Total Debt VS Total AssetsLASE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

LASE has an Altman-Z score of 21.22. This indicates that LASE is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of LASE (21.22) is better than 99.22% of its industry peers.
There is no outstanding debt for LASE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 21.22
ROIC/WACCN/A
WACC10.11%
LASE Yearly LT Debt VS Equity VS FCFLASE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

LASE has a Current Ratio of 5.38. This indicates that LASE is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of LASE (5.38) is better than 92.19% of its industry peers.
A Quick Ratio of 3.31 indicates that LASE has no problem at all paying its short term obligations.
LASE has a better Quick ratio (3.31) than 91.41% of its industry peers.
Industry RankSector Rank
Current Ratio 5.38
Quick Ratio 3.31
LASE Yearly Current Assets VS Current LiabilitesLASE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M

More info and screens

2

3. Growth

3.1 Past

LASE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.48%.
LASE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -44.08%.
The Revenue has been growing by 22.37% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-88.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.39%
Revenue 1Y (TTM)-44.08%
Revenue growth 3Y22.37%
Revenue growth 5YN/A
Sales Q2Q%-42.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LASE Yearly Revenue VS EstimatesLASE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 1M 2M 3M 4M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LASE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LASE Price Earnings VS Forward Price EarningsLASE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LASE Per share dataLASE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LASE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LASER PHOTONICS CORP

NASDAQ:LASE (7/1/2025, 8:42:01 PM)

Premarket: 2.5916 +0 (+0.06%)

2.59

-0.1 (-3.72%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-22 2025-05-22
Earnings (Next)08-11 2025-08-11
Inst Owners4.4%
Inst Owner Change71.64%
Ins Owners2.85%
Ins Owner Change0%
Market Cap35.82M
AnalystsN/A
Price TargetN/A
Short Float %11.47%
Short Ratio4.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.89
P/FCF N/A
P/OCF N/A
P/B 3.7
P/tB 6.33
EV/EBITDA N/A
EPS(TTM)-1.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.61
OCFYN/A
SpS0.19
BVpS0.7
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -103.45%
ROE -113.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.56%
FCFM N/A
ROA(3y)-7.15%
ROA(5y)N/A
ROE(3y)-7.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.39%
GM growth 5YN/A
F-Score2
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 52.26%
Cap/Sales 17.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.38
Quick Ratio 3.31
Altman-Z 21.22
F-Score2
WACC10.11%
ROIC/WACCN/A
Cap/Depr(3y)54.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.27%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.39%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.08%
Revenue growth 3Y22.37%
Revenue growth 5YN/A
Sales Q2Q%-42.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1058.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-827.65%
OCF growth 3YN/A
OCF growth 5YN/A